[go: up one dir, main page]

TN2010000402A1 - Pim kinase inhibitors and methods of their use - Google Patents

Pim kinase inhibitors and methods of their use

Info

Publication number
TN2010000402A1
TN2010000402A1 TNP2010000402A TN2010000402A TN2010000402A1 TN 2010000402 A1 TN2010000402 A1 TN 2010000402A1 TN P2010000402 A TNP2010000402 A TN P2010000402A TN 2010000402 A TN2010000402 A TN 2010000402A TN 2010000402 A1 TN2010000402 A1 TN 2010000402A1
Authority
TN
Tunisia
Prior art keywords
methods
new compounds
kinase inhibitors
pim kinase
pharmaceutically acceptable
Prior art date
Application number
TNP2010000402A
Other languages
French (fr)
Inventor
Matthew Burger
Jiong Lan
Mika Lindvall
Gisele Nishiguchi
Michelle Tetalman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2009/052506 external-priority patent/WO2009109576A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2010000402A1 publication Critical patent/TN2010000402A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to new compounds of Formulas (I) and (II), their tautomers, stereoisomers and polymorphs, and pharmaceutically acceptable salts, esters, metabolites or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the inhibition of Pirn kinase activity and/or the prophylaxis or treatment of cancer.
TNP2010000402A 2009-03-03 2010-09-01 Pim kinase inhibitors and methods of their use TN2010000402A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2009/052506 WO2009109576A1 (en) 2008-03-03 2009-03-03 Pim kinase inhibitors and methods of their use

Publications (1)

Publication Number Publication Date
TN2010000402A1 true TN2010000402A1 (en) 2011-12-29

Family

ID=55024524

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000402A TN2010000402A1 (en) 2009-03-03 2010-09-01 Pim kinase inhibitors and methods of their use

Country Status (1)

Country Link
TN (1) TN2010000402A1 (en)

Similar Documents

Publication Publication Date Title
MX2010009739A (en) Pim kinase inhibitors and methods of their use.
MX2021008356A (en) Jak2 and alk2 inhibitors and methods for their use.
MX2014014828A (en) 5-azaindazole compounds and methods of use.
MA32272B1 (en) Inhibitors of pyrazole [3,4-b] pyridine raf
CR20200286A (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
MX345928B (en) Therapeutically active compositions and their methods of use.
MX2014002683A (en) Benzonitrile derivatives as kinase inhibitors.
SG178591A1 (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
GEP20125624B (en) Pyridazine derivatives as smo inhibitors
PH12013500648A1 (en) Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors
MX2009007260A (en) Cyclized derivatives as eg-5 inhibitors.
JO3115B1 (en) Pyridazinone Compounds and Their Use as DAAO Inhibitors
MX2013003019A (en) Azabenzothiazole compounds, compositions and methods of use.
WO2017087808A8 (en) Heterocyclic compounds that inhibit the kinase activity of mnk useful for treating various cancers
MX340574B (en) Imidazo pyrazines.
IL219643A0 (en) Kinase inhibitors and methods of use thereof
TN2009000178A1 (en) Substituted pyrazole and triazole compounds as ksp inhibitors
MX2013008340A (en) Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer.
MX2013008163A (en) Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1- methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimi dazol-2-yl]urea.
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors
UA109793C2 (en) Arylsulphonamide derivatives for the treatment of disorders of the central nervous system
TN2010000402A1 (en) Pim kinase inhibitors and methods of their use
MY187891A (en) Tetrahydropyridine derivatives as fabi inhibitors
TR201901937T4 (en) 8-methyl-1-phenyl-imidazole [1,5-a] pyrazine compounds.
TN2014000077A1 (en) Pyridazinone compounds and their use as daao inhibitors